Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
K Hiroishi, J Eguchi, T Baba, T Shimazaki… - Journal of …, 2010 - Springer
Aim We investigated whether tumor-specific CD8+ T-cell responses affect tumor-free
survival as well as the relationship between CD8+ T-cell responses against tumor …
survival as well as the relationship between CD8+ T-cell responses against tumor …
[引用][C] Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular …
K HIROISHI, J EGUCHI, T BABA… - Journal of …, 2010 - jglobal.jst.go.jp
Strong CD8<sup>+</sup> T-cell responses against tumor-associated antigens prolong the
recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma …
recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma …
[引用][C] Strong CD8^+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular …
H Kazumasa, E Junichi, B Toshiyuki, S Tomoe… - Journal of …, 2010 - cir.nii.ac.jp
Strong CD8^+ T-cell responses against tumor-associated antigens prolong the recurrence-free
interval after tumor treatment in patients with hepatocellular carcinoma | CiNii Research CiNii …
interval after tumor treatment in patients with hepatocellular carcinoma | CiNii Research CiNii …
Strong CD8 (+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
K Hiroishi, J Eguchi, T Baba… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Aim We investigated whether tumor-specific CD8 (+) T-cell responses affect tumor-free
survival as well as the relationship between CD8 (+) T-cell responses against tumor …
survival as well as the relationship between CD8 (+) T-cell responses against tumor …
Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
K Hiroishi, J Eguchi, T Baba… - Journal of …, 2010 - search.ebscohost.com
We investigated whether tumor-specific CD8< sup>+ T-cell responses affect tumor-free
survival as well as the relationship between CD8< sup>+ T-cell responses against tumor …
survival as well as the relationship between CD8< sup>+ T-cell responses against tumor …
Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
K Hiroishi, J Eguchi, T Baba - Journal of Gastroenterology, 2010 - inis.iaea.org
[en] We investigated whether tumor-specific CD8+ T-cell responses affect tumor-free survival
as well as the relationship between CD8+ T-cell responses against tumor-associated …
as well as the relationship between CD8+ T-cell responses against tumor-associated …
Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
K Hiroishi, J Eguchi, T Baba, T Shimazaki… - Journal of …, 2010 - infona.pl
Aim We investigated whether tumor-specific CD8+ T-cell responses affect tumor-free
survival as well as the relationship between CD8+ T-cell responses against tumor …
survival as well as the relationship between CD8+ T-cell responses against tumor …
Strong CD8 {sup+} T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular …
K Hiroishi, J Eguchi, T Baba - Journal of Gastroenterology, 2010 - osti.gov
We investigated whether tumor-specific CD8 {sup+} T-cell responses affect tumor-free
survival as well as the relationship between CD8 {sup+} T-cell responses against tumor …
survival as well as the relationship between CD8 {sup+} T-cell responses against tumor …
Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
K Hiroishi, J Eguchi, T Baba… - Journal of …, 2010 - search.proquest.com
We investigated whether tumor-specific CD8^ sup+^ T-cell responses affect tumor-free
survival as well as the relationship between CD8^ sup+^ T-cell responses against tumor …
survival as well as the relationship between CD8^ sup+^ T-cell responses against tumor …